发明名称 |
Use of the soluble form of AXL in the diagnosis and/or prognosis of heart failure syndrome |
摘要 |
The present invention refers to a method for diagnosing and/or prognosing a heart failure syndrome (HF), which comprises the step of measuring, in vitro, the amount of the soluble form of AXL (sAXL) in a test sample. The invention furthermore provides methods for deciding or recommending whether to initiate a medical regimen, as well as for determining the efficacy of said medical regimen. The invention also provides the use of sAXL as a marker for the diagnosis and/or prognosis of HF sAXL is stable in serum and is differentially expressed in controls and people suffering from HF. |
申请公布号 |
EP2626705(A1) |
申请公布日期 |
2013.08.14 |
申请号 |
EP20120382048 |
申请日期 |
2012.02.13 |
申请人 |
INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI ISUNYER;CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS |
发明人 |
BATLLE PERALES, MONTSERRAT;GARCIA DE FRUTOS, PABLO |
分类号 |
G01N33/68 |
主分类号 |
G01N33/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|